Relapsed/Refractory Large B-cell Lymphoma With NT-I7 Post-CD19 CAR T-cell Therapy

Clinical trial NCT05075603 · COMPLETED

Trial details

NCT number: NCT05075603
Sponsor: NeoImmuneTech
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Refractory Diffuse Large B-cell Lymphoma Recurrent Diffuse Large B-Cell Lymphoma High-grade B-cell Lymphoma DLBCL Arising From Follicular Lymphoma Primary Mediastinal Large B-cell Lymphoma

Start date: 2021-07-29
Primary completion: 2024-12-18
Enrollment: 17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.